Ronald Sobecks - Concepedia

Author

Ronald Sobecks

Also Known As

Anurag Singh, John Smithhisler, R M Sobecks, R Sobecks, R. M. Sobecks, R. Sobecks, R.M. Sobecks, RM Sobecks, Ronald M Sobecks, Ronald M. Sobecks

564

Publications

6.4K

Citations

H-Index

111

Concepts

All Affiliations

Cleveland Clinic Medical College of Wisconsin Cleveland Clinic Lerner College of Medicine The University of Texas MD Anderson Cancer Center Moffitt Cancer Center

About

Ronald Sobecks is an author at Cleveland Clinic specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	78	2.7K
2	Health Sciences	19	31	1K
3	Public Health	7	7	162
4	Social Sciences	2	2	44
5	Education	1	1	21

Ronald Sobecks

143

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series Sonali M. Smith, Michelle M. Le Beau, Dezheng Huo, Blood	2003	674
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203) Javier Bolaños‐Meade, Ran Reshef, Raphael Fraser, The Lancet Haematology Versus TacrolimusTransplantationImmunosuppressive TherapyImmunologyHematology	2019	274
Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning Navneet S. Majhail, Ruta Brazauskas, J. Douglas Rizzo, Blood	2010	215
A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation Brian J. Bolwell, Ronald Sobecks, Brad Pohlman, Bone Marrow Transplantation Mycophenolate MofetilTransplantationMarrow TransplantationBone Marrow FailureGvhd Prophylaxis	2004	203
A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma M. A. Hussein, James R. Berenson, Rubén Niesvizky, Haematologica ImmunologyObserved Safety ProfilePharmacotherapyImmunotherapyMyeloid Neoplasia	2010	141
Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network Xiaorong Gu, Rita Tohmé, Benjamin Tomlinson, Leukemia	2020	99
Elevated pretransplant ferritin is associated with a lower incidence of chronic graft‐<i>versus</i>‐host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation Anuj Mahindra, Brian J. Bolwell, Ronald Sobecks, British Journal of Haematology	2009	97
Survival following allogeneic transplant in patients with myelofibrosis Krisstina Gowin, Karen K. Ballen, Kwang Woo Ahn, Blood Advances	2020	94
Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes Yogen Saunthararajah, Mikkael A. Sekeres, Anjali S. Advani, Journal of Clinical Investigation	2015	88
Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages Simone Feurstein, Amy M. Trottier, Noel Estrada‐Merly, Blood	2022	86

Page 1